Form 4 for GPCR Structure Therapeutics Inc.
Accepted 2024-03-19 00:00:00 ET · period of report 2024-03-15 · accession 0001415889-24-008566 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-19 | 2024-03-15 | GPCR | Yoon Jun | CFO | A - Grant | $0.00 | +59.5K | 1.12M | +6% | $0 |
| D | 2024-03-19 | 2024-03-15 | GPCR | Yoon Jun | CFO | A - Grant | $0.00 | +148.1K | 148.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-03-15 | A | A | 59,469 | $0.00 | 1,123,133 | D | — | — | (F1) Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one ordinary share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2024, subject to Reporting Person's continued service on such dates. |
| 2 | Derivative | Stock Option (right to buy) | 2024-03-15 | A | A | 148,134 | $0.00 | 148,134 | D | $35.25 · — to 2034-03-14 | 148,134 Ordinary Shares | (F3) 1/4th of the shares subject to the option shall vest March 1, 2025, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date. |